Engineering epidermal growth factor for enhanced mitogenic potency
暂无分享,去创建一个
Alan Wells | H. Steven Wiley | Douglas A. Lauffenburger | D. Lauffenburger | H. Wiley | A. Wells | Cartikeya C. Reddy | Salil K. Niyogi | S. Niyogi | C. Reddy | H. Wiley | Salil K. Niyogi
[1] D. Lauffenburger,et al. Receptor‐mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor α , 1996, Journal of cellular physiology.
[2] A. Wells,et al. Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis , 1994, The Journal of cell biology.
[3] D. Lauffenburger,et al. Proliferative Response of Fibroblasts Expressing Internalization‐Deficient Epidermal Growth Factor (EGF) Receptors Is Altered via Differential EGF Depletion Effect , 1994, Biotechnology progress.
[4] Anita B. Roberts,et al. Peptide Growth Factors and Their Receptors I , 1990, Springer Study Edition.
[5] H. Wiley,et al. Genetically modified skin to treat disease: potential and limitations. , 1994, The Journal of investigative dermatology.
[6] Zining Wu,et al. A Point Mutation in Interleukin-2 That Alters Ligand Internalization* , 1996, The Journal of Biological Chemistry.
[7] D A Lauffenburger,et al. Intracellular Trafficking of Epidermal Growth Factor Family Ligands Is Directly Influenced by the pH Sensitivity of the Receptor/Ligand Interaction (*) , 1995, The Journal of Biological Chemistry.
[8] W. Meyer-Ingold,et al. Wound therapy: growth factors as agents to promote healing. , 1993, Trends in biotechnology.
[9] J. Vacanti,et al. Tissue engineering : Frontiers in biotechnology , 1993 .